Companies formed

Since 1987, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and in recent years has spun out 15-20 new companies every year.

Over £2.5bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and ten of our current portfolio are currently listed in London and New York.

The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.

2020

Research and experimental development on biotechnology.

Incorporated in July 2020

Origin: Oxford University, Oncology

Aim is to accelerate and streamline research through an innovative digital platform for knowledge sharing.

Incorporated in July 2020

Origin: Oxford University, Tropical Medicine

A lean spin-out, social enterprise focusing on developing a fast rapid COVID-19 test. Joint Oxford University and OSCAR company.

Incorporated in June 2020

Origin: Oxford University, Department of Engineering Science

DNA methylation detection using this TAPS technology. Base Genomics was acquired by Exact Sciences in October 2020.

Incorporated in June 2020

Origin: Oxford University, Ludwig Institute for Cancer Research

High heat flux technology. The company will provide advanced engineering solutions to challenging thermal problems such as those that occur in fusion reactors, or high power density electronic systems.

Incorporated in April 2020

Origin: Oxford University, Thermofluids Institute

Contact: Adrian Coles

Development of a platform for the standardisation of assetments to facility language, reading and arithmetic skills in children.

Incorporated in April 2020

Origin: Oxford University, Department of Education

Improving the lives of people living with Parkinson’s.

Incorporated in March 2020

Origin: Oxford University, Department of Physiology, Anatomy and Genetics

Contact: Richard Auburn

2019

Malaria vaccine development.

Incorporated in September 2019

Origin: Oxford University, Jenner Institute

GryeOx addresses significant unmet need in drug discovery as the IP can make expanded drug libra of macrocycles in the hit to lead stage.

Incorporated in July 2019

Origin: Oxford University

DNA assembly.

Incorporated in July 2019

Origin: Oxford University

Platform technology based on NG capture-c technique computational pipelines and experimental know-how.

Incorporated in July 2019

Origin: Oxford University, MRC Weatherall Institute of Molecular Medicine

Contact: Matthew Carpenter

"CRIS" software that enables submission, de-identification and sharing of mental health patient records using a federated data and information governance model.

Incorporated in May 2019

Origin: Oxford University, Psychiatry

Sparks Background Image

Ready to get in touch?

Contact Us
Sparks Background Image
© Oxford University Innovation